Şenol H.Özgün-Acar Ö.Dağ A.Eken A.Acar B.Aktaş Pepe N.Güner H.Aykut Z. G.Çevik Kaplan S.Ayaz Güner Ş.et al.2023-02-252023-02-252022-09-26Şenol H., Özgün-Acar Ö., Dağ A., Eken A., Acar B., Aktaş Pepe N., Güner H., Aykut Z. G., Çevik Kaplan S., Ayaz Güner Ş., et al., \"Preclinical studies evaluating the therapeutic efficacy of novel natural compound olean-12-en-28-ol, 3β pentacosanoate for multiple sclerosis\", I. International Advances in Molecular Biology Congress, İstanbul, Türkiye, 19 - 22 Eylül 2022, ss.55-56https://hdl.handle.net/20.500.12645/37115info:eu-repo/semantics/openAccessYaşam BilimleriMoleküler Biyoloji ve GenetikTemel BilimlerLife SciencesMolecular Biology and GeneticsNatural SciencesTemel Bilimler (SCI)Yaşam Bilimleri (LIFE)Doğa Bilimleri GenelÇOK DİSİPLİNLİ BİLİMLERNatural Sciences (SCI)Life Sciences (LIFE)NATURAL SCIENCES, GENERALMOLECULAR BIOLOGY & GENETICSMULTIDISCIPLINARY SCIENCESMoleküler BiyolojiMultidisiplinerMolecular BiologyMultidisciplinaryPreclinical studies evaluating the therapeutic efficacy of novel natural compound olean-12-en-28-ol, 3β pentacosanoate for multiple sclerosisconferenceObject